Concise review: Clinical relevance of drug drug and herb drug interactions mediated by the ABC transporter ABCB1 (MDR1, P-glycoprotein)
- PMID: 17766652
- DOI: 10.1634/theoncologist.12-8-927
Concise review: Clinical relevance of drug drug and herb drug interactions mediated by the ABC transporter ABCB1 (MDR1, P-glycoprotein)
Abstract
The importance of P-glycoprotein (P-gp) in drug-drug interactions is increasingly being identified. P-gp has been reported to affect the pharmacokinetics of numerous structurally and pharmacologically diverse substrate drugs. Furthermore, genetic variability in the multidrug resistance 1 gene influences absorption and tissue distribution of drugs transported. Inhibition or induction of P-gp by coadministered drugs or food as well as herbal constituents may result in pharmacokinetic interactions leading to unexpected toxicities or undertreatment. On the other hand, modulation of P-gp expression and/or activity may be a useful strategy to improve the pharmacological profile of anticancer P-gp substrate drugs. In recent years, the use of complementary and alternative medicine (CAM), like herbs, food, and vitamins, by cancer patients has increased significantly. CAM use substantially increases the risk for interactions with anticancer drugs, especially because of the narrow therapeutic window of these compounds. However, for most CAMs, it is unknown whether they affect metabolizing enzymes and/or drug transporter activity. Clinically relevant interactions are reported between St John's wort or grapefruit juice and anticancer as well as nonanticancer drugs. CAM-drug interactions could explain, at least in part, the large interindividual variation in efficacy and toxicity associated with drug therapy in both cancer and noncancer patients. The study of drug-drug, food-drug, and herb-drug interactions and of genetic factors affecting pharmacokinetics and pharmacodynamics is expected to improve drug safety and will enable individualized drug therapy. Disclosure of potential conflicts of interest is found at the end of this article.
Similar articles
-
20(S)-ginsenoside Rh2 noncompetitively inhibits P-glycoprotein in vitro and in vivo: a case for herb-drug interactions.Drug Metab Dispos. 2010 Dec;38(12):2179-87. doi: 10.1124/dmd.110.034793. Epub 2010 Sep 13. Drug Metab Dispos. 2010. PMID: 20837659
-
Dietary regulation of P-gp function and expression.Expert Opin Drug Metab Toxicol. 2009 Jul;5(7):789-801. doi: 10.1517/17425250902997967. Expert Opin Drug Metab Toxicol. 2009. PMID: 19545213 Review.
-
Herb-drug interactions in oncology: focus on mechanisms of induction.Oncologist. 2006 Jul-Aug;11(7):742-52. doi: 10.1634/theoncologist.11-7-742. Oncologist. 2006. PMID: 16880233 Review.
-
Potential for interaction of kava and St. John's wort with drugs.J Ethnopharmacol. 2005 Aug 22;100(1-2):108-13. doi: 10.1016/j.jep.2005.05.014. J Ethnopharmacol. 2005. PMID: 16005588 Review.
-
Pharmacokinetic interactions of drugs with St John's wort.J Psychopharmacol. 2004 Jun;18(2):262-76. doi: 10.1177/0269881104042632. J Psychopharmacol. 2004. PMID: 15260917 Review.
Cited by
-
Critical Assessment of Phenotyping Cocktails for Clinical Use in an African Context.J Pers Med. 2023 Jul 5;13(7):1098. doi: 10.3390/jpm13071098. J Pers Med. 2023. PMID: 37511712 Free PMC article. Review.
-
Pharmacokinetic interaction of voriconazole and clarithromycin in Pakistani healthy male volunteers: a single dose, randomized, crossover, open-label study.Front Pharmacol. 2023 Jun 9;14:1134803. doi: 10.3389/fphar.2023.1134803. eCollection 2023. Front Pharmacol. 2023. PMID: 37361220 Free PMC article.
-
Canine and feline P-glycoprotein deficiency: What we know and where we need to go.J Vet Pharmacol Ther. 2023 Jan;46(1):1-16. doi: 10.1111/jvp.13102. Epub 2022 Nov 3. J Vet Pharmacol Ther. 2023. PMID: 36326478 Free PMC article. Review.
-
Association between Single Nucleotide Polymorphisms of SULT1A1, SULT1C4, ABCC2 and Phase II Flavanone Metabolites Excretion after Orange Juice Intake.Nutrients. 2022 Sep 13;14(18):3770. doi: 10.3390/nu14183770. Nutrients. 2022. PMID: 36145145 Free PMC article.
-
Advances in Hydrogel-Based Microfluidic Blood-Brain-Barrier Models in Oncology Research.Pharmaceutics. 2022 May 5;14(5):993. doi: 10.3390/pharmaceutics14050993. Pharmaceutics. 2022. PMID: 35631579 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous